DX D Biotech T 5 Bull 2X ETFTBXUETF
13F holders, Q3 2025 (September 30)1holders
$25.00avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding DX D Biotech T 5 Bull 2X ETF (TBXU) in their 13F filings. The largest holder was Goldman Sachs Group Inc. ($625K).
- Company
- DX D Biotech T 5 Bull 2X ETF
- Filed as
- DIREXION SHS ETF TR (Q3 2025)
- CUSIP
- 25461H101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $625K |
| Exits | 0 | $0 |
Ownership 1 holders
| Goldman Sachs Group Inc. | 0.00% | New | 25,000 | $625K |
"% of holder's portfolio" is TBXU's weight in each manager's 13F, not the share of DX D Biotech T 5 Bull 2X ETF the manager owns.